INTRODUCTION
The pulmonary kinetics of granulocytes have been widely investigated with respect to the role of these cells in acute lung damage [l-51. Unlike capillaries elsewhere, lung capillaries have a calibre similar to or less than that of a granulocyte, which therefore undergoes mechanical deformation during transit through the pulmonary vascular bed [6-91. Granulocytes have been seen, under direct observation, to undergo discrete periods of immobilization as they negotiate pulmonary capillaries [lo] . Under pathological conditions, granulocytes may become activated as a result of exposure to inflammatory mediators, either in the circulation or locally at a site of inflammation [ 111. This increases their mechanical stiffness, probably via effects on the cytoskeleton [8] , and delays their lung transit. It has been widely suggested that such prolonged transit results in lung damage [l-51. In the steady state, the number of granulocytes in the lung vasculature reflects the mean intrapulmonary vascular transit time. This population can be described as the pulmonary granulocyte pool (PGP) and, without implying a specific mechanism of intrapulmonary granulocyte transit, regarded as the sum of regional marginating and circulating granulocyte pools. It can be expressed as a fraction of the whole body total blood granulocyte pool (TBGP) by comparing the lung counts at 15 min after injection of 99"Tc-labelled granulocytes with the first-pass counts on dynamic gamma-camera imaging, as recently described and validated [ 121. Under normal circumstances it is reasonable to suppose that there is no significant migration of granulocytes into the extravascular space of the lung. As we have recently reported [ 131, extravascular migration into lung parenchyma can be quantified from gammacamera images obtained 24h after injection of " 'In-labelled granulocytes, when there are no longer any circulating labelled cells [14] .
The PGP and extravascular migration can be measured separately using the same population of granulocytes, double labelled with 9 9 m T~ (for measuring PGP) and '"In (for measuring migration) [IS] . Thus, the superior counting statistics of 9 9 m T~ can be exploited for a dynamic study, while the greater cellular stability [14] and longer physical half-life of ' "In lend themselves to delayed imaging.
With these techniques, therefore, we aimed to identify the separate roles of extravascular granulocyte migration and intravascular granulocyte pooling in the pathogenesis of lung injury by correlating them with granulocyte activation in v i m , measured by a simple but robust shape-change assay, and with the rate of clearance of inhaled 99mTc-diethylenetriaminepenta-acetic acid (DTPA) as an index of lung injury, in patients with extrapulmonary inflammatory diseases. These were inflammatory bowel disease (IBD) and systemic vasculitis, in which abnormalities of pulmonary granulocyte traftic have previously been demonstrated [16, 171 , and graft versus host disease complicating bone marrow transplantation in which we have also frequently seen prominent lung activity early after injection of labelled granulocytes.
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Patients
A total of 23 non-smoking adult patients were studied, of whom 18 had systemic inflammation. They all received double-labelled granulocytes with quantification of PGP (based on 9 9 m T~) and pulmonary extravascular granulocyte migration (based on "'In). Six were referred for labelled granulocyte scintigraphy for the evaluation of suspected IBD or for follow-up of known IBD (three with ulcerative colitis, three with Crohn's disease; age range 22-50 years). All had abnormal focal accumulation of cells in the gastrointestinal tract indicating active IBD. Eight patients had clinically active systemic vasculitis (two with Behqet's disease, four with Wegener's granulomatosis, two with anti-neutrophilic cytoplasmic antibody-positive systemic vasculitis; age range 26-73 years), and four had abdominal graft versus host disease complicating bone marrow transplantation performed for chronic myeloid Ieukaemia (age range 33-52 years). Clinical management of the 18 patients was variable, although the vasculitic patients received prednisolone and azathioprine and all the bone marrow transplant recipients were on cyclosporin; they had also received total body irradiation and cyclophosphamide for conditioning before transplantation. Minor and variable abnormalities of lung function were documented in the vasculitic and transplant patients but in none of those with IBD.
In addition, five patients referred for suspected osteomyelitis from the Department of Surgery with a painful hip or knee prosthesis were included in the study. None gave a history of pyrexia during the month preceding referral, and, at the time of the study, each remained apyrexial and had a C-reactive protein level, leucocyte count and erythrocyte sedimentation rate in the normal range. They also all had negative granulocyte scans and a painful joint which was considered to be non-infected on clinical follow-up of at least 4 months. We therefore considered these five patients as negative for systemic inflammatory disease and used them as controls (patient controls). As none of these patient controls had a 99"Tc-DTPA clearance study, we studied five healthy non-smoking volunteers (normal controls) to obtain normal clearance tllz values.
Double % and "Tc granulocyte labelling
This technique and its potential advantages have recently been described and discussed in detail [l5]. Briefly, 80-100ml of venous blood was withdrawn through a 19-G butterfly cannula, anticoagulated with 20ml of acid citrate dextrose (NIH Formula A), mixed with 10ml of 6% hydroxyethyl starch solution and allowed to stand for 40-50min to allow erythrocyte sedimentation. The leucocyte-rich plasma was removed and the granulocyte fraction isolated by discontinuous plasma-Percoll gradient centrifugation (50, 55 and 60%) using platelet-poor plasma. After isolation, the granulocytes were resuspended in 0.5ml of platelet-poor plasma and labelled first with "'In-tropolonate
[lS] and then with 99mTc-hexamethylpropylenamine oxime (HMPAO)' [14] as follows. Nine to fifteen MBq of "'In in 1 0 0~1 of tropolone were added to the granulocyte pellet which was incubated at room temperature for 5 min. Two millilitres of freshly prepared 99"Tc-HMPA0 (Ceretec, Amersham International plc, U.K.) (370-490 MBq) were added to the suspension and incubated for a further 10min. The labelling was terminated by adding 20ml of platelet-rich plasma. The labelled cells were then sedimented by centrifugation at 150g for 5 min. The cell pellet was resuspended with 1.5ml of cell-free plasma and reinjected into the patient. An aliquot was retained for the assessment of granulocyte activation (see below). Using this technique, each cell was labelled with both '"In and 99mTc HMPAO; 148 (SD 12) MBq of 99mTc and 6.8 (0.2) MBq of "'In were injected.
Granulocyte kinetic studies
All studies were performed with a Starcam (International General Electric) large field-of-view gamma-camera on-line to a dedicated computer (Starimager; International General Electric) for sub-sequent analysis. The labelled cells were injected via a 19-G butterfly cannula as a bolus and a 30-min dynamic study was acquired in the 9 9 m T~ gamma photopeak. Regions of interest (ROI) were placed over the right ventricle and right lung and timeactivity curves generated for quantification of PGP, as previously described [l2]. Conventional planar scans were recorded on the "'In photopeak at 24h after injection. One of the posterior views encompassed the middle and lower lobes of the lungs and the pelvis. ROIs were drawn over the right lung and posterior iliac bone marrow (adjacent to the sacroiliac joint) and the average count rate per pixel was calculated, corrected for '' 'In physical decay and expressed in relation to the acquisition time, size of ROI and injected activity as c.p.m. MBq-' pixel-'. We have previously shown that in normal subjects the chest and iliac bone marrow "'In uptake on 24 h " 'In-granulocyte scans correlated with each other [13] . Assuming no granulocytes migrated into the lung interstitium in these subjects, the interstitial lung signal in the current study was calculated from (right lung ROI uptake) -0.23 x (iliac bone marrow ROI uptake) [13] and used as an index of pulmonary granulocyte migration on the grounds that by 24 h there are no longer any intravascular labelled cells [14, 191 .
Measurement of granulocyte activation
The activation of granulocytes was quantified using a shape-change technique which measures granulocyte polarization consequent upon cytoskeletal assembly [20] . Measured activation represents the effects of activating stimuli present in uiuo before granulocyte isolation and ex uiuo as a result of the preparative method. A 0.1 ml aliquot of granulocyte suspension in plasma was withdrawn from the cell pellet isolated for labelling and transferred to a 15ml conical polyethylene tube. It was then made up to lOml with Hanks' buffered saline solution free of Ca2+ and Mg2+. While making up the volume, cells were resuspended gently with a plastic Pasteur pipette. They were then centrifuged at 150g for 4 min and the supernatant decanted. The cell pellet was resuspended in 0.5ml of Hanks' buffered saline solution with Cat+ and Mg2+ and incubated for 10 min at 37°C. The cells were then fixed with 0.5 ml of 2% glutaraldehyde. Activation was quantified as the percentage of cells showing a change in shape on microscope counting. The test was not performed in one of the patient controls. The effect of labelling itself was investigated in samples from 10 subjects (four healthy controls and six of the patients with systemic inflammation) by comparing shape change in aliquots withdrawn from the cell pellet before and immediately after double labelling.
*Tc-DTPA inhalation clearance studies
Alveolocapillary permeability was measured after the completion of 24h "'In imaging in 17 of the 18 patients with systemic inflammation. With the gamma-camera positioned posteriorly over the chest and upper abdomen, the supine patient inhaled 99"Tc-DTPA aerosol via an Intersurgical jet inhaler for 4min. Lung clearance was monitored for 60min. Lung background activity was subtracted using an ROI over the liver and a separate intravenous injection of 99"Tc-DTPA, as described previously [Zl] . Each background-corrected clearance curve was displayed on a logarithmic ordinate and fitted by least squares to a mono-exponential or biexponential function, depending on which was closer on maximum likelihood criteria [22] . The overall t l l z was calculated as the time to halfmaximum lung count rate, irrespective of the number of exponentials present.
Statistics
Non-parametric statistics were used throughout: Wilcoxon rank sum and signed rank sum methods for comparison of independent and paired samples, respectively, and Spearman rank correlation coefficient (Rs) for associations between variables, A P value of less than 0.05 was taken to represent statistical significance.
The study was approved by the local Ethics Committee of Hammersmith Hospital and the Administration of Radioactive Substances Advisory Committee of the Department of Health. Informed consent was obtained from patients and volunteers.
RESULTS
There was no significant change in granulocyte activation after labelling in comparison with activation present before labelling; i.e. immediately after isolation from blood. Thus, average cell activation in four normal volunteers was 9.8% before labelling and 10.1% after labelling, and in six patients with systemic inflammatory conditions it was 32% before and 34% after labelling.
Values for PGP, granulocyte activation, migration index and t l l z of 99"Tc-DTPA clearance are illustrated in Fig. 1 . The migration index tended to be bimodal in each of the three patient groups. The above variables were significantly different compared with patient controls in patients with vasculitis (except for migration) and in bone marrow transplant recipients (except for migration and DTPA tl12). In IBD, on the other hand, none of the variables were significantly different compared with patient controls.
Combining patients from all groups, there were strong associations between the tllz of 99"' Tc-DTPA clearance and the migration index (Rs = -0.84, n = 17, P ~0 . 0 1 ) and between granulocyte activation and PGP (Rs=0.72, n=22, P<O.Ol) (Fig. 2) . Significant but weaker associations were noted between migration and PGP (Rs =0.58, n = 23), and between migration and activation (Rs = 0.52, n = 22). The associations between 99"Tc-DTPA clearance tllz In view of the tendency towards a bimodal distribution of migration indices in the patients with systemic inflammation, we next examined the differences between patients without and those with significant migration. The 17 patients with a complete data set comprised: (i) six with an expanded PGP (>20%) but a migration index within the normal range ( < 0.2 c.p.m. MBq -' pixel-'); (ii) nine with an expanded PGP and an increased migration index; (iii) one with increased migration but normal PGP; and (iv) one with normal pulmonary granulocyte kinetics. The nine patients with increased migration and increased PGP had significantly higher values of PGP and 99"Tc-DTPA clearance rates than the six with a raised PGP but no migration signal ( Table 1) . Their granulocyte activation, however, was not significantly higher. Patients with an expanded PGP but no increased migration had 99mTc-DTPA clearance rates that were not significantly different from normal controls.
DISCUSS10 N
In the patient control group, the PGP was quite close to the lung blood volume expressed as a fraction of total blood volume [23], suggesting that, although a small number of cells may undergo prolonged retention, there is normally only minimal granulocyte retention in the lung vasculature. This is consistent with quantitative studies of the whole body distribution of granulocytes in normal subjects [24] . In contrast, as we have shown previously [l2], PGP may be increased in patients with systemic inflammation. Less attention has been paid to extravascular granulocyte migration in the lung, possibly because it is diffrcult to quantify, even by bronchopulmonary lavage. We have developed a technique for quantifying migration [ 131 based on the residual "'In signal in the lung after 24h when it is reasonable to assume that labelled cells in the lung will all have migrated. Although some authors, directly observing pulmonary capillaries through skin windows, have described the presence of granulocytes sequestered in pulmonary capillaries for periods of many minutes to hours [7-lo] , these must represent an increasingly small minority of the pulmonary granulocyte population, even in patients with an expanded PGP, otherwise in due course a very large fraction of the whole body TBGP would accumulate in the pulmonary vasculature. Granulocyte activation was assessed by the simple, rapid, robust and well-validated method of determining the proportion of cells exhibiting shapechange during 10min incubation at 37°C [ZO]. This assay assesses the effect of activating stimuli upon polarization of cytoskeletal elements and is therefore of direct relevance for assessing whether re-infused granulocytes are likely to be retarded during passage through the pulmonary capillaries because of reduced deformability [25, 261. Furthermore the assay has the advantage that activation is assessed on an all-or-nothing basis for individual cells. Other assays of granulocyte activation, such as N-formylmethionyl-leucyl-phenylalanine stimulated superoxide production or flow cytometric demonstration of increased CD1 l b expression, reflect a continuous property of the whole population of cells and their relevance to the ability of granulocytes to deform and traverse the pulmonary circulation is uncertain. Granulocytes were activated in several patients with systemic inflammation. The mechanisms of activation have not been addressed in this study. In several studies based on shape-change techniques or flow cytometry, increased activation of granulocytes has been shown in vasculitis found an accelerated 99"Tc-DTPA clearance in Crohn's disease. In the current study we observed a significant correlation between the migration signal and the t l l z of 99mTc-DTPA clearance. Furthermore, patients with bi-exponential ""Tc-DTPA clearances had significantly higher migration signals than patients with mono-exponential clearances. However, several patients who had an increased PGP and activated granulocytes had little evidence of parenchymal migration. As a group, these patients had no evidence of lung injury insofar as their ""Tc-DTPA clearance was not significantly different from normal subjects. Unlike the systemic vascular bed, in which granulocytes gain access to the extravascular space by migrating across post-capillary venules, granulocytes in the lung migrate through the capillary endothelium [40] . Thus, consistent with clinical [41] and animal data [40, 42, 431 , it seems likely that granulocytes have to migrate across this endothelial barrier to cause damage to lung parenchyma. Although a migration signal was absent in an appreciable number of patients with increased PGP, the latter was significantly higher in the presence of migration, consistent with the hypothesis that migration occurs above a critical level of pulmonary granulocyte margination. Our data does not, however, exclude the possibility that intravascular granulocytes, adherent to the pulmonary endothelium, may cause endothelial damage [44] , since the rate-limiting barrier for the lung clearance of inhaled 99"Tc-DTPA is the alveolar epithelium rather than the vascular endothelium. Thus, indices of lung injury based, for example, on the accumulation of radiolabelled protein in the pulmonary interstitial space, could potentially be elevated in the presence of intravascular granulocyte accumulation without migration.
In conclusion, systemic inflammation is associated with increased granulocyte activation and pulmonary granulocyte pooling. Our data are consistent with the hypothesis that a further increase in pooling is associated with migration. Interstitial lung damage does not, however, result from intravascular pooling by itself but also requires extravascular migration. A sequence can therefore be proposed in which lung injury is the end result of granulocyte activation, leading to pulmonary granulocyte margination, increasing margination and extravascular migration. Further work is required to more clearly define the aetiological role of pulmonary granulocytes in diffuse lung damage.
